ALFA Finder| Revenue growth | 22% YoY growth in Q1FY27 |
|---|---|
| Margins | EBITDA margins improved to 14.6% from 14.1% YoY |
| Demand visibility | Strong traction in Products; Services emerging as key growth engine |
| Management confidence | Confident in sustainable growth and long-term value creation |
Growth
Revenue reached Rs 56.9 Cr (+22% YoY); EBITDA grew 27% to Rs 8.3 Cr; PAT grew 25% to Rs 4 Cr.
Outlook
Expect to acquire remaining 24% stake in Saarathi Healthcare by end of Q2FY27 to strengthen disease management capabilities.
Risks
Regulatory limits on direct promotions in India and competitive pressures in the medical device distribution space.
Last quarter's promises, checked
Delivered
- Guided FY26 EBITDA margin ~15% → delivered 15% (= BEAT)
- Guided FY27 Revenue INR 216 Cr → Q1FY27 run-rate INR 227.6 Cr (= BEAT)
- Guided Services margin 25% → delivered 25% (= BEAT)
Partly delivered
- Guided doubling Services revenue mix → reached 41% from 31% (= PARTIAL)
Missed
- Guided FY26 EBITDA 17% → delivered 15% (= MISS)
Investor Presentation filed with NSE, NSE: QMSMEDI. Summary written with AI assistance from the document.
QMS Medical Allied Services Ltd: key numbers
- Share price
- ₹170.59
- Market cap
- ₹329.9 Cr
- Revenue (annual)
- ₹172.9 Cr
- Net profit (annual)
- ₹11.92 Cr
- P/E (TTM)
- 27.7×Sector 54.5×
- Promoter holding
- 68.11%+0.00% QoQ
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from QMS Medical Allied Services Ltd
All →QMS Medical Allied Services Annual General Meeting
QMS Medical Allied Services Limited held its 9th Annual General Meeting on September 30, 2026. Shareholders approved a 5% final dividend and adoption of financial results.
QMS Medical Allied Services Acquisition
QMS Medical Allied Services Limited is acquiring BeamOptics Scientific Private Limited. The strategic acquisition aims to expand the company's addressable market in healthcare business.
- Execution
- on or before 30th November, 2027
QMS Medical Allied Services Business Update
QMS Medical Allied Services executed a shareholders' agreement with investors and its subsidiary, Saarathi Healthcare, defining governance rights, veto powers, and share transfer restrictions.
QMS Medical Allied Services Merger & Restructuring
QMS Medical Allied Services Limited approved a composite demerger scheme for its healthcare business and the acquisition of a 100% stake in BeamOptics Scientific Private Limited.
QMS Medical Allied Services Acquisition Worth ₹14.22 Cr
QMS Medical Allied Services Ltd acquired the remaining 24% stake in Saarathi Healthcare Private Limited for Rs. 14.23 Crore, making it a wholly-owned subsidiary.
- Value
- ₹14.22 Cr
QMS Medical Allied Services Other Announcement
QMS Medical Allied Services Limited informed the exchange regarding the dispatch of annual report links to shareholders who haven't registered their email addresses.